A. An administrator shall ensure that:
- 1. A medical record is established and maintained for each participant according to A.R.S. Title 12, Chapter 13, Article 7.1;
2. An entry in a participant’s medical record is:
- a. Recorded only by a personnel member authorized by policies and procedures to make the entry;
- b. Dated, legible, and authenticated; and
- c. Not changed to make the initial entry illegible;
3. An order is:
- a. Dated when the order is entered in the participant’s medical record and includes the time of the order;
- b. Authenticated by a medical practitioner or behavioral health professional according to policies and procedures; and
- c. If the order is a verbal order, authenticated by the medical practitioner or behavioral health professional issuing the order;
- 4. If a rubber-stamp signature or an electronic signature is used to authenticate an order, the individual whose signature the rubber-stamp signature or electronic signature represents is accountable for the use of the rubber-stamp signature or electronic signature;
5. A participant’s medical record is available to an individual:
- a. Authorized according to policies and procedures to access the participant’s medical record;
- b. If the individual is not authorized according to policies and procedures, with the written consent of the participant or the participant’s representative; or
- c. As permitted by law; and
- 6. A participant’s medical record is protected from loss, damage, or unauthorized use.
B. If a substance abuse transitional agency maintains participants’ medical records electronically, an administrator shall ensure that:
- 1. Safeguards exist to prevent unauthorized access, and
- 2. The date and time of an entry in a medical record is recorded by the computer’s internal clock.
C. An administrator shall ensure that a participant’s medical record contains:
1. Participant information that includes:
- a. The participant’s name;
- b. The participant’s address;
- c. The participant’s date of birth; and
- d. Any known allergies, including medication allergies;
- 2. A participant’s presenting behavioral health issue;
- 3. Documentation of general consent and, if applicable, informed consent for treatment by the participant or the participant’s representative, except in an emergency;
4. If applicable, the name and contact information of the participant’s representative and:
- a. The document signed by the participant consenting for the participant’s representative to act on the participant’s behalf; or
b. If the participant’s representative:
- i. Has a health care power of attorney established under A.R.S. § 36-3221 or a mental health care power of attorney executed under A.R.S. § 36-3282, a copy of the health care power of attorney or mental health care power of attorney; or
- ii. Is a legal guardian, a copy of the court order establishing guardianship;
- 5. Documentation of medical history and results of a physical examination;
- 6. The date of admission and, if applicable, date of discharge;
- 7. Orders;
- 8. Assessment;
- 9. Progress notes;
- 10. Documentation of substance abuse transitional agency services provided to the participant;
- 11. If applicable, documentation of any actions taken to control the participant’s sudden, intense, or out-of-control behavior to prevent harm to the participant or another individual;
- 12. The disposition of the participant upon discharge;
- 13. The discharge plan;
- 14. A discharge summary, if applicable; and
15. Documentation of a medication administered to a participant that includes:
- a. The date and time of administration;
- b. The name, strength, dosage, and route of administration;
c. For a medication administered for pain:
- i. An evaluation of the participant’s pain before administering the medication, and
- ii. The effect of the medication administered;
d. For a psychotropic medication:
- i. An evaluation of the participant’s behavior before administering the psychotropic medication, and
- ii. The effect of the psychotropic medication administered;
- e. The signature of the individual administering the medication; and
- f. Any adverse reaction a participant has to the medication.
Historical Note
Adopted effective February 1, 1994 (Supp. 94-1). Section repealed; new Section made by exempt rulemaking at 19 A.A.R. 2015, effective October 1, 2013 (Supp. 13-2). Section R9-10-1410 renumbered to R9-10-1409; new Section R9-10-1410 renumbered from R9-10-1411 and amended by exempt rulemaking at 20 A.A.R. 1409, pursuant to Laws 2013, Ch. 10, § 13; effective July 1, 2014 (Supp. 14-2).